Study Evaluating the Safety and Efficacy of Brimonidine Tartrate Ophthalmic Solution in Adult and Geriatric Subjects

Eye Therapies, LLC

Status and phase: Completed; Phase 2

Conditions: Ocular Redness

Treatments: Drug: Placebo; Drug: Brimonidine tartrate 0.025%

Study type: Interventional

Funder types: Industry

Identifiers

NCT01675609

11-100-0015

Details and patient eligibility

About

The purpose of this study is to evaluate the safety and efficacy of brimonidine tartrate 0.025% ophthalmic solution used four times daily in a population of adult and geriatric subjects

Enrollment: 57 patients

Sex: All

Ages: 40+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Be at least 40 years of age
• Must have normal ocular health
• Must have history of redness relief drop use or desire to use

Exclusion criteria

• Must not have any ocular/systemic health problems
• Must agree to avoid disallowed medications

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

57 participants in 2 patient groups, including a placebo group

Placebo

Placebo Comparator group

Treatment:

Drug: Placebo

Brimonidine Tartrate 0.025%

Experimental group

Treatment:

Drug: Brimonidine tartrate 0.025%